FDA approves ‘Magic Mushroom’ Trials

FDA approves ‘Magic Mushroom’ Trials

FDA approves ‘Magic Mushroom’ psilocy bin therapy Trial for treatment-resistant Depression. Compass Pathways has received approval from the US FDA for a Clinical Trial using psilocy bin, The active ingredient in magic Mushroom.